In lieu of an abstract, here is a brief excerpt of the content:

>> 243 Bibliography ACOG [American Congress of Obstetricians and Gynecologists]. 2009. “Routine screening for hereditary breast and ovarian cancer recommended.” http://www. acog.org/About_ACOG/News_Room/News_Releases/2009/Routine_Screening_for_Hereditary_Breast_and_Ovarian_Cancer_Recommended (accessed October 22, 2012). ACOG [American Congress of Obstetricians and Gynecologists] Committee on Practice Bulletins. 1999. “ACOG Practice Bulletin No. 7: Prophylactic oopherorectomy .” International Journal of Gynecology & Obstetrics 67 (3): 193–99. ———.2008. “ACOG Practice Bulletin No. 89: Elective and risk-reducing salpingo oophrectomy.” Obstetrics and Gynecology 111 (1): 231–41. Ahmed, M., and N. Rahman. 2006. “ATM and breast cancer susceptibility.” Oncogene 25:5906–11. Aliyu, Muktar H., et al. 2005. “Trends in birth across high-parity groups by race/ ethnicity and maternal age.” Journal of the National Medical Association 6 (June): 799–804. Allsopp, Michelle, Ruth Stringer, and Paul Johnston. 2008. Unseen Poisons: Levels of Organochlorine Chemicals in Human Tissues. http://archive.greenpeace.org/ toxics/reports/unseenpo.pdf (Accessed November 27, 2012). Amend, Kandace, David Hicks, and Christine B. Ambrosone. 2006. “Breast cancer in African-American women: Differences in tumor biology from EuropeanAmerican women.” Cancer Research 66 (September 1): 8327–30. American Cancer Society. 2005. “Cancer facts and figures 2005.” On file with author. ———.2012. “Cancer facts and figures 2012.” http://www.cancer.org/Cancer/OvarianCancer /DetailedGuide/ovarian-cancer-key-statistics (accessed October 22, 2012). Angèle, Sandra, and Janet Hall. 2000. “The ATM gene and breast cancer: Is it really a risk factor?” Mutation Research 462 (2–3): 167–78. Angier, Natalie. 1994. “Breast cancer gene isn’t making screening easy.” New York Times, November 30. Armstrong, Katrina, et al. 2004. “Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: A decision analysis.” Journal of Clinical Oncology 22 (6): 1045–54. ———.2005. “Racial differences in the use of BRCA1/2 testing among women with 244 > 245 Barbara A. Koenig, Sandra Soo-Jin Lee, and Sarah S. Richardson, 70–85. New Brunswick: Rutgers University Press. Boswell-Penc, Maia. 2006. Tainted Milk: Breastmilk, Feminisms, and the Politics of Environmental Degradation. Albany: State University of New York Press. Bourne, Thomas H., et al. 1991. “Ultrasound screening for familial ovarian cancer.” Gynecologic Oncology 43 (2): 92–97. Braun, Lundy. 2002. “Race, ethnicity, and health. Can genetics explain disparities?” Perspectives in Biology and Medicine 45 (2): 159–75. Brawley, Otis. 2002. “Disaggregating the effects of race and poverty on breast cancer outcomes.” Journal of the National Cancer Institute 94 (7): 471–73. ———.2003a. “Cancer and health disparities.” Cancer and Metastasis Reviews 22 (1): 7–9. ———.2003b. “Population categorization and cancer statistics.” Cancer and Metastasis Reviews 22 (1): 11–19. Breast Cancer Action. 2011. “Breast Cancer Action says IOM report misses important opportunities to turn the tide on the epidemic.” December 11. http:// bcaction.org/2011/12/07/breast-cancer-action-says-iom-report-misses-important -opportunities-to-turn-the-tide-on-the-epidemic/ (accessed November 9, 2012). Breast Cancer Fund. 2006. “New California environmental health program will measure pollution in people.” ———and Commonweal. N.d. “Biomonitoring and Senate Bill 1379: Myths vs. facts.” www.ncel.net/articles/biomonitoring.Myths.Facts.final.doc (accessed November 9, 2012). “Breast cancer mythology on Long Island.” 2002. New York Times, August 31. “Breast cancer risk likely higher for lesbians.” 1998. Arizona Republic, August 29. Broder, Michael S., David E. Kanouse, Brian S.Mittman, and Steven J. Bernstein. 2000. “The appropriateness of recommendations for hysterectomy. ” Obstetrics and Gynecology 95 (2): 199–205. Brooks, Jamie L., and Meredith L. King. 2008. “Geneticizing disease: Implications for racial health disparities.” Center for American Progress. January. http://www. americanprogress.org/issues/2008/01/geneticizing_disease.html (accessed October 23, 2012). Brown, Michael K., Martin Carnoy, Elliot Currie, and Troy Duster. 2003. WhiteWashing Race: The Myth of the Color-Blind Society. Berkeley: University of California Press. Brown, Phil. 1987. “Popular epidemiology: Community response to toxic wasteinduced disease in Woburn, MA.” Science, Technology, and Human Values 12 (Summer–Fall): 78–85. ———.2007. Toxic Exposures: Contested Illnesses and the Environmental Health Movement. New York: Columbia University Press. ———, Rachel Morello-Frosch, Stephen Zavestoski, and the Contested Illnesses 246 > 247 populationhealthcenters/cphhd/documents/CPHHD_report.pdf (accessed July 11, 2012). Chafe, William H. 1999. The Unfinished Journey: America since World War II. New York: Oxford University Press. Chen, Yumay, et al. 1995. “Aberrant subcellular localization of BRCA1 in breast cancer.” Science 270 (5237): 789–91. Chlebowski, Rowan T., et al. 2009. “Breast cancer after use of estrogen plus progestin in postmenopausal women.” New England Journal of Medicine 360 (6): 573–86. Chowkwanyun, Merlin. 2011...

Share